Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0779-2017Class III

DELFIA hFSH kit. In Vitro Diagnostic for the determination of hFSH in serum

Revvity Health Sciences, Inc. / initiated 2016-11-16 / Terminated

PerkinElmer Health Sciences, Inc. began a recall of DELFIA hFSH kit. In Vitro Diagnostic for the determination of hFSH in serum on . FDA classified it as Class III and gives the reason as "A DELFIA hFSH kit lot failed real time stability testing. The real time stability data demonstrated a decrease in hFSH concentrations between -4.8% to -11.3% for control sera. The -11.3% bias was observed at an hFSH...". As of , the recall status on record is Terminated.

Recall record

Recall number
Z-0779-2017
Classification
Class III
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Revvity Health Sciences, Inc.
Product
DELFIA hFSH kit. In Vitro Diagnostic for the determination of hFSH in serum
Product code
CGJ Radioimmunoassay, Follicle-Stimulating Hormone
Reason for recall
A DELFIA hFSH kit lot failed real time stability testing. The real time stability data demonstrated a decrease in hFSH concentrations between -4.8% to -11.3% for control sera. The -11.3% bias was observed at an hFSH target concentration of 101 IU/L. The change observed in the serum samples within the range 1.76 67.0 IU/L hFSH averaged -2.9%. The reference range of the assay spans 0.60 to 98.0 IU/L.
FDA root cause
Other
Action
PerkinElmer initiated recall on November 16, 2016, delivered to the end customer by email facilitated through the PerkinElmer Technical Support group located in Akron Ohio. Technical Support will be asked to make sure the customers receive the Recall Letter and understand the recommended actions. Users asked to inspect inventory, discontinue use destroy the kits and complete the Response Forms and Destruction.Replacement kits will shipped.
Quantity in commerce
79 kits
Distribution
CA, CO, NY, WA Foreign: Austria, Bolivia, Bosnia , Sweden, Norway, Netherlands, Japan, Great Britain,
Product codes and lots
Lot Number: 646091

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0779-2017
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0779-2017Class IIITerminatedVoluntary: Firm initiated